Shweta Joshi

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions”.

Targeting the Tumor Microenvironment in Neuroblastoma: Recent Advances and Future Directions

Cancers(2020)10.3390/cancers12082057

N/A

0DataRank · unranked

82 citations

Shweta Joshi

“Re-educating” Tumor Associated Macrophages as a Novel Immunotherapy Strategy for Neuroblastoma

Frontiers in Immunology(2020)10.3389/fimmu.2020.01947

N/A

0DataRank · unranked

69 citations

Shweta Joshi, Kevin X. Liu

A triple action CDK4/6-PI3K-BET inhibitor with augmented cancer cell cytotoxicity

Cell Discovery(2020)10.1038/s41421-020-0181-z

N/A

0DataRank · unranked

15 citations

Kendra R. Vann, Shweta Joshi, Guillermo Morales, Francisco M. De La Vega, Alok Singh +5 more

The BTK/PI3K/BRD4 axis inhibitor SRX3262 overcomes Ibrutinib resistance in mantle cell lymphoma

iScience(2021)10.1016/j.isci.2021.102931

N/A

0DataRank · unranked

14 citations

Kendra R. Vann, Shweta Joshi, Namood-e Sahar, Guillermo Morales, Dalia El‐Gamal +3 more

Augmented Antitumor Activity for Novel Dual PI3K/BDR4 Inhibitors, SF2523 and SF1126 in Ewing Sarcoma

Journal of Pediatric Hematology/Oncology(2021)10.1097/mph.0000000000002054

N/A

0DataRank · unranked

7 citations

Alok Singh, Shweta Joshi, Christina Jamieson, Donald L. Durden, Amanda N. Goldin

Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy

Pharmacology & Therapeutics(2022)10.1016/j.pharmthera.2022.108114

N/A

0DataRank · unranked

136 citations

Andrew B. Sharabi, Shweta Joshi

Syk Inhibition Reprograms Tumor-Associated Macrophages and Overcomes Gemcitabine-Induced Immunosuppression in Pancreatic Ductal Adenocarcinoma

Cancer Research(2023)10.1158/0008-5472.can-22-3645

N/A

0DataRank · unranked

45 citations

In Hwan Park, Timothy V. Pham, Jonathan Weitz, Tatiana Hurtado de Mendoza, Suresh Madheswaran +9 more

Targeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma

Frontiers in Immunology(2023)10.3389/fimmu.2023.1148317

N/A

0DataRank · unranked

19 citations

In Hwan Park, Timothy V. Pham, Riley N. Jones, Elisabette Tapia, Kevin X. Liu +5 more

983 Syk promotes macrophage immunosuppressive phenotype to suppress anti-tumor immunity

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0983

N/A

0DataRank · unranked

0 citations

Suresh Madheswaran, Shweta Joshi, Deepak Rohila